JENNIFER DUNHAM: Open Payments
NPI 1821338443 · CHARLOTTE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,702 in 140 payments from 29 companies in 2025. Trend: 2023 $504 · 2024 $2,725 · 2025 $2,702
Food & beverage: $2,702
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 21 | $422 |
| AstraZeneca Pharmaceuticals LP | 12 | $230 |
| ABBVIE INC. | 13 | $229 |
| ViiV Healthcare Company | 9 | $229 |
| Lilly USA, LLC | 9 | $187 |
| Sumitomo Pharma America, Inc. | 6 | $150 |
| PFIZER INC. | 10 | $146 |
| Novo Nordisk Inc | 10 | $143 |
| Exact Sciences Corporation | 5 | $107 |
| Merck Sharp & Dohme LLC | 5 | $105 |
Products named: JARDIANCE, APRETUDE, GEMTESA, Cologuard Collection Kit, UBRELVY, VRAYLAR, PREVNAR 20, VOQUEZNA.
Industry payments across NC — which companies pay providers there.
